TerminatedNCT01139125

An Open Trial of Cysteamine Treatment in Schizophrenia

Medication studyAges 18–60United States

The study in practice

Understand this study

This study is for people with schizophrenia. Listed age limits: 18 years to 60 years. Other eligibility criteria apply.

Listed locations: Augusta and 1 more locationSee all locations and recruitment

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateSeptember 2009

Recruitment status: Terminated
Enrollment listed in the registry: 3
Sponsor: Augusta University
Sponsor type: University
Study type: Drug
Intervention type: Medication / drug
Study phase: Not clearly listed
Locations: United States
Age range: From 18 Years to 60 Years
Official registry ID: NCT01139125
Official title: Show the full official title
An Open Trial of Cysteamine Treatment in Schizophrenia

Terminated

Augusta

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Augusta University, a university.

Does this study involve medication?

Yes. The study involves medication, including (Cystagon) Cysteamine Bitartrate.

Who can participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 60 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.